Status:

ACTIVE_NOT_RECRUITING

Prognostic Impact of Neopterin on Resumption of Walking After a Fracture of the Upper Neck of the Femur in the Elderly

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

Institut National de la Santé Et de la Recherche Médicale, France

Conditions:

Fracture of Neck of Femur

Resumption of Walking

Eligibility:

All Genders

75-110 years

Phase:

NA

Brief Summary

Society faces a major challenge with the management of the health and socio-economic burden caused by acute physical stress in the older population (\>75 years). In particular, hip fracture (HF) repre...

Detailed Description

Hip fracture (HF) is a common condition affecting an estimated 2 million older people worldwide and that number is increasing by 25% each decade as the population continues to grow. HF has serious cli...

Eligibility Criteria

Inclusion

  • For both arms:
  • age over 75
  • affiliated to health insurance system
  • written informed consent
  • For arm 'Fracture':
  • patient with a fracture of the upper neck of the femur
  • hospitalized in emergency in a 'UPOG' unit
  • For arm 'control':
  • hospitalized patient without any acute clinical event

Exclusion

  • For both arms:
  • polytrauma
  • pathological bone or prothesis fracture
  • patient affiliated to 'Aide Médical de l'Etat - AME' insurance
  • patient with immunosuppressant treatment (including corticotherapy over 5 mg/d)
  • patient with active solid cancer or malignant haemopathy
  • patient with auto-immune disease
  • refusal to participate in research
  • For arm 'Fracture':
  • patient under justice protection measure except tutorship and guardianship
  • For arm 'control':
  • severe neurocognitive disorders (MMS \< 15)
  • fracture of the upper neck of the femur in the last year
  • patient under justice protection measure

Key Trial Info

Start Date :

May 16 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2025

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT05233072

Start Date

May 16 2022

End Date

September 1 2025

Last Update

February 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

GH Pitié-Salpêtrière / Service de gériatrie

Paris, Île-de-France Region, France, 75013

Prognostic Impact of Neopterin on Resumption of Walking After a Fracture of the Upper Neck of the Femur in the Elderly | DecenTrialz